COMMITTEES WORLDWIDE
We bring together distinguished personalities of the highest stature to promote new standards of excellence.
Our committees are actively involved in defining the Galien Foundation agenda, of iterating the issues brought forth for debate, and of shedding light on the tremendous achievements man has made to improve the human condition.
United Kingdom Committee
- Colin DOLLERY, Senior Consultant, R&D and Former Vice Chancellor, GlaxoSmithKline and London University
- Stephen EVANS, Professor, Pharmacoepidemiology, London School of Hygiene and Tropical Medicine (LSHTM)
- John FRY, Former Senior Treasurer, General Medical Council
- Parveen KUMAR, Professor, Medicine and Education and Honorary Consultant Physician and Gastroenterologist, London School of Medicine & Dentistry, Queen Mary University of London and Barts & The London NHS Trust, Homerton University Hospital Foundation Trust
- Michael LANCASTER-SMITH, Retired Consultant Physician & Gastroenterologist,
- Mark PORTER, Presenter, Inside Health; Medical Correspondent;and Doctor, BBC Radio 4, The Times, and the One Show
- June RAINE, Director, Vigilance and Risk Management Medicines, Medicines and Healthcare products Regulatory Agency (MHRA)
- Sir Michael RAWLINS, Chair and Chairman, Medicines and Healthcare products Regulatory Agency (MHRA) and UK BioBank
- Michael RICHARDS, Chief Inspector of Hospitals, Care Quality Commission
- Philip ROUTLEDGE, Honorary Consultant Physician and Clinical Pharmacologist and Head, Department of Pharmacology, Therapeutics and Toxicology, Cardiff and Vale University Health Board and Cardiff University School of Medicine
- Liam SMEETH, Professor, Clinical Epidemiology and Head, Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine
- Simon THOMAS, Consultant Physician and Professor, Clinical Pharmacology and Therapeutics and Director, National Poisons Information Service (Newcastle) Unit and the UK Teratology Information Service, Newcastle Hospitals NHS Foundation Trust and Newcastle University
- Paul TURNER, Former Vice President, Royal Society of Medicine
- Sir John VANE, (In memoriam) (Nobel Laureate) Honorary Professor, Yale university and King's College, London
- David J WEBB, Christison Professor of Therapeutics and Clinical Pharmacology and President-Elect, Queen’s Medical Research Institute and Royal Infirmary of Edinburgh and British Pharmacological Society